lysine has been researched along with osimertinib in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, Y; Feng, D; Liu, X; Zheng, M; Zhong, D | 1 |
| Campos, S; Evans, JP; Fournier, JCL; Patel, VK; Thomas, DA; Tomkinson, NCO; White, GV; Zappacosta, F | 1 |
| Chen, J; Chen, L; Diao, X; He, Q; Wu, Y; Xue, H; Zhong, D | 1 |
3 other study(ies) available for lysine and osimertinib
| Article | Year |
|---|---|
Characterization of covalent binding of tyrosine kinase inhibitors to plasma proteins.
Topics: Acrylamides; Adenine; Aminoquinolines; Aniline Compounds; Animals; Binding Sites; Dogs; Haplorhini; Humans; Indoles; Lysine; Mice; Molecular Docking Simulation; Molecular Structure; Piperidines; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Quinolines; Rabbits; Rats; Serum Albumin, Human | 2020 |
Acetylation of the Catalytic Lysine Inhibits Kinase Activity in PI3Kδ.
Topics: Acetylation; Acrylamides; Adenine; Afatinib; Amino Acid Sequence; Aniline Compounds; Catalysis; Catalytic Domain; Class I Phosphatidylinositol 3-Kinases; Humans; Lysine; Mass Spectrometry; Molecular Docking Simulation; Phosphoinositide-3 Kinase Inhibitors; Piperidines; Protein Binding; Protein Conformation; Substrate Specificity | 2021 |
Covalent Binding Mechanism of Furmonertinib and Osimertinib With Human Serum Albumin.
Topics: Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; Lysine; Serum Albumin; Serum Albumin, Human | 2023 |